DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
Srpski
English
Русский
INTERFERENCE IN IMMUNOASSAY MEASUREMENTS OF TSH AND THYROID HORMONES AFTER VACCINE FOR COVID-19 OR COVID-19 DISEASE
English
Clinic of endocrinology, diabetes and diseases of Metabolism, University Clinical Centre, Belgrade, Serbia
Faculty of medicine, University of Belgrade, Serbia
Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Practice & Research Clinical Endocrinology & Metabolism 2013; 27: 647–661. https://doi.org/10.1016/j.beem.2013.05.011
Başok Banu Işbilen. Understanding and managing biotin interference in immunoassays. Int J Med Biochem. 2020. https://doi.org/10.14744/ijmb.2020.48303
Kabiri P, Weiskirchen R, van Helden J. The biotin interference within interference suppressed immunoassays. J Clin Lab Anal 2021; 35: e23940. https://doi.org/10.1002/ jcla.23940
INTERFERENCE IN IMMUNOASSAY MEASUREMENTS OF TSH AND THYROID HORMONES AFTER VACCINE FOR COVID-19 OR COVID-19 DISEASE
THE IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS IN THE GENERAL HOSPITAL “DR. LAZA K. LAZAREVIĆ”, ŠABAC
English
milijanadamnjanovic77@gmail.comPediatrics department, General hospital “Dr Laza K. Lazarevic”, Šabac, Serbia
Center for disease control and prevention, Institute of Public Health Sabac, Šabac, Serbia
American Diabetes Association Professional Practice Committee; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S17–S38. https://doi.org/10.2337/dc22-S002
Gomber A, Ward ZJ, Ross C, Owais M, Mita C, Yeh JM, Reddy CL, Atun R. Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review. PLOS Glob Public Health. 2022 Nov 9;2(11):
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):7–19
THE IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS IN THE GENERAL
HOSPITAL “DR. LAZA K. LAZAREVIĆ”, ŠABAC
SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders, Zlatibor,
Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021; 39(7): 1282–1292.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17: 543–58.
SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION
NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor
D Atri, HK Siddiqi, J Lang, V Nauffal, DA Morrow, Bohula EA. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 202
Terpos I, Ntanasis-Stathopoulos I, Elalamy E, Kastritis TN, Sergentanis M, Politou T, et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020; 95: 834–847. https://doi.org/10.1002/ajh.25829.
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020; 191: 9–14. https://doi.org/ 10.1016/j
NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY
Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506.
Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020; 192: 152–160.
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID- 19 pneumonia: a random association? Eur Heart J. 2020; 41( 19):1858.
Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection
CONTACT US